Target intelligence / Profile preview

Toll-like receptor 4 (TLR4)

Target
TLR4
Molecular classification
Pattern Recognition Receptor (PRR), Toll-like Receptor
01

Overview

Toll-like receptor 4 (TLR4), also known as CD284, is an essential pattern recognition receptor (PRR) that detects both microbial invaders via PAMPs—especially bacterial LPS—and endogenous danger signals via DAMPs. Its activation triggers complex signaling cascades leading to inflammation necessary for pathogen clearance but potentially harmful if uncontrolled. It is a transmembrane protein of approximately 95 kDa encoded by the TLR4 gene and belongs to the toll-like receptor family. TLR4 plays a central role in detecting microbial components, especially lipopolysaccharides (LPS) from Gram-negative bacteria, initiating rapid activation of innate immunity. It also recognizes endogenous DAMPs released during tissue injury or cell death, such as HMGB1 and S100 proteins. Activation of TLR4 leads to proinflammatory responses that are crucial for fighting infections but can also contribute to acute and chronic inflammatory diseases if dysregulated.

Other names
CD284
02

Mechanism of action

Modulation of TLR4 signaling pathways (MyD88-dependent and TRIF-dependent), typically aimed at inhibiting downstream inflammatory cytokine production.

03

Biological functions

Innate ImmunitySignal TransductionInflammationPathogen RecognitionDAMP RecognitionAntigen Presentation
04

Disease associations

SepsisAutoimmune DiseasesMetabolic Disorders (e.g., Diabetes Mellitus Type II)Chronic Inflammatory ConditionsInfection
05

Safety considerations

Potential for immunosuppressionIncreased risk of infectionExacerbation of inflammatory responses if dysregulatedOff-target effects due to broad expression profile

Beyond the preview

Go deeper on Toll-like receptor 4 (TLR4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toll-like receptor 4 (TLR4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call